Latest financial market updates and expert analysis
Chemicals Investors hoping for a decisive turnaround at Bayer were met with sobering news as the company released its full-year results. While the German conglomerate met its operational targets for 2025,...
In a market environment characterized by shifting dynamics for collateralized loan obligations (CLOs), the Carlyle Credit Income fund emphasizes a...
For stakeholders in Dong Fang Hui Le, a company specializing in senior wellness and care services, the current market environment...
Clearway Energy has announced an increase in its quarterly dividend, continuing its established pattern of returning capital to investors. The...
Lumen Technologies finds itself navigating a difficult and multi-faceted corporate overhaul. The company’s strategic pivot from legacy telecommunications services toward...
The iShares Biotechnology ETF (IBB) is navigating a critical juncture, with conflicting signals emerging from market participants. While some technical...
Investor attention is turning to Tvardi Therapeutics as the biopharmaceutical company approaches several significant clinical data readouts in the first...
Pharmaceutical giant Eli Lilly faces a pivotal regulatory milestone in March 2026, with the U.S. Food and Drug Administration (FDA)...
Investor attention is once again converging on a singular event for Take-Two Interactive: the launch of Grand Theft Auto VI....
Innovative Industrial Properties (IIPR), a real estate investment trust specializing in specialized properties, is emphasizing capital discipline and portfolio diversification....
A notable surge in bearish sentiment is emerging around SunHydrogen, even as the company announces concrete progress toward commercial manufacturing....
